ProfileGDS4718 / 204797_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 32% 93% 37% 44% 61% 42% 39% 54% 42% 44% 40% 40% 41% 41% 59% 49% 44% 34% 44% 54% 52% 50% 54% 44% 35% 53% 28% 41% 47% 25% 69% 43% 29% 45% 71% 29% 52% 32% 94% 43% 30% 65% 75% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7493335
GSM549102patient 115, normal, homogenized [OPG study]4.632432
GSM549104patient 119, normal, homogenized [OPG study]9.7662693
GSM549108patient 138, normal, homogenized [OPG study]4.9107337
GSM549119patient 077, normal, homogenized [OPG study]5.2046244
GSM549133patient 032, cancer, homogenized [OPG study]6.1660761
GSM549139patient 042, cancer, homogenized [OPG study]5.0747442
GSM549099patient 107, normal, homogenized [OPG study]4.95539
GSM549109patient 139, normal, homogenized [OPG study]5.7681754
GSM549110patient 046, normal, homogenized [OPG study]5.0990842
GSM549114patient 063, normal, homogenized [OPG study]5.1456344
GSM549122patient 082, normal, homogenized [OPG study]5.004640
GSM549134patient 033, cancer, homogenized [OPG study]4.961140
GSM549136patient 036, cancer, homogenized [OPG study]4.9961241
GSM549140patient 044, cancer, homogenized [OPG study]4.9755541
GSM549111patient 047, normal, homogenized [OPG study]6.095359
GSM549113patient 057, normal, homogenized [OPG study]5.3815949
GSM549132patient 031, cancer, homogenized [OPG study]5.1667644
GSM549137patient 038, cancer, homogenized [OPG study]4.6740334
GSM549142patient 047, cancer, homogenized [OPG study]5.3208444
GSM549100patient 110, normal, homogenized [OPG study]5.7638354
GSM549107patient 135, normal, homogenized [OPG study]5.5802652
GSM549115patient 068, normal, homogenized [OPG study]5.4489150
GSM549116patient 072, normal, homogenized [OPG study]5.724954
GSM549120patient 078, normal, homogenized [OPG study]5.1999144
GSM549131patient 030, cancer, homogenized [OPG study]4.7067835
GSM549118patient 074, normal, homogenized [OPG study]5.6910253
GSM549129patient 027, cancer, homogenized [OPG study]4.4712828
GSM549123patient 088, normal, homogenized [OPG study]5.0143641
GSM549124patient 006, cancer, homogenized [OPG study]5.3792447
GSM549126patient 015, cancer, homogenized [OPG study]4.308725
GSM549128patient 025, cancer, homogenized [OPG study]6.8761869
GSM549103patient 117, normal, homogenized [OPG study]5.2143343
GSM549117patient 073, normal, homogenized [OPG study]4.4972429
GSM549138patient 041, cancer, homogenized [OPG study]5.2468845
GSM549141patient 045, cancer, homogenized [OPG study]7.0671
GSM549130patient 028, cancer, homogenized [OPG study]4.5234529
GSM549101patient 111, normal, homogenized [OPG study]5.6537252
GSM549105patient 128, normal, homogenized [OPG study]4.6587632
GSM549106patient 134, normal, homogenized [OPG study]10.189894
GSM549112patient 048, normal, homogenized [OPG study]5.133943
GSM549125patient 011, cancer, homogenized [OPG study]4.5670230
GSM549127patient 024, cancer, homogenized [OPG study]6.555165
GSM549135patient 035, cancer, homogenized [OPG study]7.4616675